PriceTargets.com logo

Centene - CNC Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $83.92
  • Forecasted Upside: 42.00%
  • Number of Analysts: 14
  • Breakdown:
  • 0 Sell Ratings
  • 7 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$59.10 As of 11/20/2024 01:00 AM ET
▲ +1.29 (2.23%)

This chart shows the closing price for CNC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Centene Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CNC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CNC

Analyst Price Target is $83.92
▲ +42.00% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for Centene in the last 3 months. The average price target is $83.92, with a high forecast of $95.00 and a low forecast of $66.00. The average price target represents a 42.00% upside from the last price of $59.10.

This chart shows the closing price for CNC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 14 polled investment analysts is to moderate buy stock in Centene. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 11 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
5/30/2023
  • 0 strong buy ratings
  • 7 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 9 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
5/24/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 9 hold ratings
  • 0 sell ratings
Ratings as of
8/22/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
10/21/2024
  • 0 strong buy ratings
  • 7 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
11/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 7 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/4/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$91.00 ➝ $90.00
10/30/2024Sanford C. BernsteinLower TargetOutperform ➝ Outperform$96.00 ➝ $88.00
10/29/2024BarclaysLower TargetOverweight ➝ Overweight$97.00 ➝ $91.00
10/25/2024Robert W. BairdLower TargetNeutral ➝ Neutral$83.00 ➝ $66.00
10/1/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00 ➝ $90.00
9/20/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00 ➝ $90.00
9/13/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$93.00 ➝ $91.00
9/10/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00 ➝ $90.00
9/5/2024BarclaysLower TargetOverweight ➝ Overweight$98.00 ➝ $97.00
8/22/2024BarclaysBoost TargetOverweight ➝ Overweight$90.00 ➝ $98.00
8/19/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00 ➝ $90.00
8/5/2024StephensReiterated RatingEqual Weight ➝ Equal Weight$78.00 ➝ $78.00
8/5/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$81.00 ➝ $93.00
8/2/2024Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$82.00 ➝ $87.00
7/31/2024TD CowenBoost TargetBuy ➝ Buy$80.00 ➝ $89.00
7/29/2024OppenheimerLower TargetOutperform ➝ Outperform$110.00 ➝ $95.00
7/24/2024TD CowenLower TargetBuy ➝ Buy$91.00 ➝ $80.00
7/24/2024Jefferies Financial GroupDowngradeBuy ➝ Hold$83.00 ➝ $69.00
7/23/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00 ➝ $90.00
7/22/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$93.00 ➝ $81.00
7/15/2024Truist FinancialLower TargetBuy ➝ Buy$92.00 ➝ $89.00
7/11/2024Jefferies Financial GroupLower TargetBuy ➝ Buy$90.00 ➝ $83.00
7/10/2024JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$85.00 ➝ $80.00
6/21/2024OppenheimerReiterated RatingOutperform ➝ Outperform$110.00 ➝ $110.00
6/12/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00 ➝ $90.00
5/30/2024Baird R WUpgradeHold
5/30/2024StephensReiterated RatingEqual Weight ➝ Equal Weight$83.00 ➝ $83.00
5/30/2024Robert W. BairdInitiated CoverageNeutral$83.00
5/2/2024BarclaysBoost TargetOverweight ➝ Overweight$101.00 ➝ $104.00
4/30/2024Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$81.00 ➝ $82.00
4/29/2024OppenheimerReiterated RatingOutperform ➝ Outperform$110.00 ➝ $110.00
4/15/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$89.00 ➝ $93.00
4/8/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$94.00 ➝ $89.00
4/4/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00
3/21/2024StephensReiterated RatingOverweight ➝ Equal Weight$92.00 ➝ $85.00
3/20/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$90.00 ➝ $94.00
3/6/2024BarclaysInitiated CoverageOverweight$101.00
1/2/2024Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$82.00 ➝ $90.00
12/21/2023Truist FinancialBoost TargetBuy ➝ Buy$83.00 ➝ $86.00
12/21/2023UBS GroupBoost TargetNeutral ➝ Neutral$72.00 ➝ $79.00
12/15/2023Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$82.00 ➝ $90.00
12/13/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$74.00 ➝ $82.00
11/21/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$82.00
10/26/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$71.00 ➝ $74.00
10/9/2023Jefferies Financial GroupLower TargetBuy ➝ Buy$82.00 ➝ $81.00
9/14/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$82.00
9/5/2023Bank of AmericaUpgradeUnderperform ➝ Neutral$79.00 ➝ $72.00
8/30/2023Morgan StanleyDowngradeOverweight ➝ Equal Weight$94.00 ➝ $73.00
7/31/2023OppenheimerReiterated RatingOutperform ➝ Outperform$110.00
7/31/2023StephensLower Target$87.00 ➝ $85.00
7/31/2023BarclaysLower TargetOverweight$86.00 ➝ $85.00
7/14/2023Morgan StanleyReiterated RatingOverweight ➝ Overweight$94.00
7/12/2023Wolfe ResearchDowngradeOutperform ➝ Peer Perform
7/11/2023MizuhoLower Target$80.00 ➝ $76.00
7/7/2023JPMorgan Chase & Co.Lower Target$81.00 ➝ $77.00
6/20/2023Truist FinancialLower Target$88.00 ➝ $83.00
6/20/2023UBS GroupInitiated CoverageNeutral$72.00
4/26/2023StephensLower Target$95.00 ➝ $87.00
4/26/2023Credit Suisse GroupLower Target$94.00 ➝ $87.00
4/26/2023BarclaysLower Target$90.00 ➝ $86.00
4/20/2023Cantor FitzgeraldInitiated CoverageOverweight$80.00
4/11/2023BarclaysLower TargetOverweight$93.00 ➝ $90.00
3/21/2023Wells Fargo & CompanyLower TargetEqual Weight$79.00 ➝ $71.00
3/9/2023Morgan StanleyLower TargetOverweight$103.00 ➝ $94.00
3/8/2023Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$94.00 ➝ $79.00
2/28/2023MizuhoLower TargetNeutral$92.00 ➝ $80.00
2/23/2023JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$94.00 ➝ $90.00
2/14/2023CowenLower TargetOutperform$101.00 ➝ $97.00
2/8/2023The Goldman Sachs GroupLower TargetNeutral$97.00 ➝ $74.00
2/8/2023MizuhoReiterated RatingNeutral$92.00
2/8/2023JPMorgan Chase & Co.Lower TargetOverweight$98.00 ➝ $94.00
2/8/2023Loop CapitalLower Target$110.00 ➝ $95.00
2/8/2023BarclaysLower TargetOverweight$100.00 ➝ $93.00
1/6/2023JPMorgan Chase & Co.Lower TargetOverweight$103.00 ➝ $98.00
12/19/2022Credit Suisse GroupBoost TargetOutperform$104.00 ➝ $106.00
12/14/2022ArgusBoost Target$95.00 ➝ $99.00
12/13/2022Bank of AmericaDowngradeNeutral ➝ Underperform$100.00 ➝ $85.00
10/26/2022Deutsche Bank AktiengesellschaftLower Target$99.00 ➝ $94.00
10/3/2022BarclaysLower TargetOverweight$107.00 ➝ $100.00
9/30/2022ArgusInitiated CoverageBuy$90.00
9/22/2022CowenLower Target$108.00 ➝ $101.00
9/22/2022CowenLower Target$108.00 ➝ $101.00
8/26/2022Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$103.00 ➝ $99.00
8/9/2022CowenBoost Target$108.00
7/28/2022BarclaysInitiated CoverageOverweight ➝ Overweight$107.00
7/27/2022StephensBoost TargetOutperform$110.00
7/27/2022OppenheimerBoost TargetOutperform$110.00
7/27/2022Truist FinancialBoost TargetOutperform$102.00 ➝ $110.00
7/27/2022Deutsche Bank AktiengesellschaftBoost Target$91.00 ➝ $99.00
7/19/2022Credit Suisse GroupSet Target$97.00
7/14/2022Jefferies Financial GroupUpgradeHold ➝ Buy$82.00 ➝ $115.00
7/14/2022Truist FinancialBoost TargetBuy$100.00 ➝ $102.00
6/23/2022Morgan StanleyLower TargetOverweight$112.00 ➝ $103.00
6/22/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$88.00 ➝ $91.00
6/21/2022Credit Suisse GroupUpgradeNeutral ➝ Outperform$86.00 ➝ $88.00
6/16/2022Loop CapitalInitiated CoverageBuy$100.00
5/26/2022Sanford C. BernsteinInitiated CoverageOutperform$111.00 ➝ $108.00
5/26/2022Bank of AmericaDowngradeBuy ➝ Neutral$95.00 ➝ $90.00
5/25/2022Wells Fargo & CompanyLower TargetOverweight$96.00 ➝ $95.00
2/9/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$84.00 ➝ $88.00
2/9/2022MizuhoBoost TargetNeutral$78.00 ➝ $84.00
1/11/2022Sanford C. BernsteinBoost Target$94.00 ➝ $108.00
1/7/2022BarclaysInitiated CoverageOverweight ➝ Overweight$95.00
1/5/2022Truist FinancialBoost TargetBuy ➝ Buy$94.00 ➝ $96.00
12/17/2021Morgan StanleyBoost TargetOverweight$86.00 ➝ $109.00
12/14/2021The Goldman Sachs GroupInitiated CoverageNeutral$83.00
12/13/2021Truist FinancialBoost TargetBuy$90.00 ➝ $94.00
12/13/2021Wolfe ResearchBoost TargetOutperform$72.00 ➝ $80.00
12/13/2021StephensBoost TargetOverweight ➝ Overweight$82.00 ➝ $102.00
12/13/2021Bank of AmericaBoost TargetBuy$85.00 ➝ $93.00
12/13/2021OppenheimerBoost TargetOutperform ➝ Outperform$90.00 ➝ $95.00
12/13/2021Wells Fargo & CompanyBoost TargetOverweight$88.00 ➝ $90.00
12/13/2021Credit Suisse GroupBoost TargetNeutral ➝ Neutral$75.00 ➝ $86.00
12/13/2021BMO Capital MarketsBoost TargetOutperform ➝ Outperform$93.00 ➝ $100.00
12/13/2021MizuhoBoost TargetNeutral ➝ Neutral$70.00 ➝ $78.00
11/1/2021CitigroupDowngradeBuy ➝ Neutral$77.00
10/27/2021Credit Suisse GroupBoost TargetNeutral$70.00 ➝ $75.00
10/27/2021Morgan StanleyBoost TargetOverweight$79.00 ➝ $86.00
9/14/2021Credit Suisse GroupLower TargetNeutral$73.50 ➝ $70.00
9/14/2021Morgan StanleyLower TargetOverweight$88.00 ➝ $79.00
9/9/2021CowenInitiated CoverageOutperform$87.00
9/8/2021MizuhoLower TargetNeutral$75.00 ➝ $67.00
8/31/2021Morgan StanleyLower TargetOverweight$94.00 ➝ $88.00
8/17/2021Roth CapitalInitiated CoverageBuy
8/3/2021Wells Fargo & CompanyLower TargetOverweight$93.00 ➝ $88.00
7/9/2021Seaport Res PtnReiterated RatingBuy
6/17/2021CitigroupBoost TargetBuy ➝ Buy$80.00 ➝ $86.00
6/17/2021Wells Fargo & CompanyBoost TargetOverweight$87.00 ➝ $93.00
6/17/2021OppenheimerReiterated RatingBuy$90.00
6/17/2021BMO Capital MarketsBoost TargetPositive ➝ Outperform$88.00 ➝ $93.00
6/17/2021MizuhoBoost TargetNeutral$65.00 ➝ $75.00
6/8/2021Bank of AmericaBoost TargetBuy$75.00 ➝ $85.00
5/24/2021Wells Fargo & CompanyInitiated CoverageOverweight$87.00
5/18/2021Wells Fargo & CompanyInitiated CoverageOverweight$87.00
5/11/2021BMO Capital MarketsBoost TargetOutperform$77.00 ➝ $88.00
5/11/2021StephensUpgradeEqual Weight ➝ Overweight$71.00 ➝ $87.00
4/28/2021BMO Capital MarketsLower Target$88.00 ➝ $77.00
3/15/2021MizuhoInitiated CoverageNeutral$65.00
3/9/2021MizuhoInitiated CoverageNeutral$65.00
1/21/2021The Goldman Sachs GroupInitiated CoverageNeutral
1/15/2021Jefferies Financial GroupDowngradeBuy ➝ Hold$75.00 ➝ $72.00
12/21/2020Deutsche Bank AktiengesellschaftLower TargetBuy$83.00 ➝ $77.00
12/14/2020Leerink PartnersLower TargetOutperform$80.00 ➝ $75.00
11/11/2020Piper SandlerBoost TargetOverweight$83.00 ➝ $89.00
10/28/2020Credit Suisse GroupLower TargetNeutral$72.50 ➝ $67.50
10/28/2020Deutsche Bank AktiengesellschaftLower TargetBuy$87.00 ➝ $83.00
10/28/2020Leerink PartnersBoost TargetOutperform$78.00 ➝ $80.00
9/22/2020StephensDowngradeOverweight ➝ Equal Weight
9/22/2020BarclaysBoost TargetOverweight$72.00 ➝ $84.00
7/29/2020Jefferies Financial GroupLower TargetBuy$85.00 ➝ $83.00
7/29/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$80.00 ➝ $87.00
7/1/2020Leerink PartnersInitiated CoverageOutperform$78.00
6/12/2020OppenheimerInitiated CoverageBuy$90.00
4/29/2020Bank of AmericaReiterated RatingBuy$82.00
4/29/2020Credit Suisse GroupReiterated RatingHold$72.50
4/29/2020CitigroupBoost TargetBuy$70.00 ➝ $81.00
4/29/2020OppenheimerBoost TargetOutperform$83.00 ➝ $90.00
4/29/2020Deutsche Bank AktiengesellschaftLower TargetBuy$82.00 ➝ $80.00
4/28/2020OppenheimerReiterated RatingBuy$83.00
4/13/2020Morgan StanleyBoost TargetOverweight$85.00 ➝ $89.00
4/13/2020SunTrust BanksBoost TargetBuy$85.00 ➝ $90.00
3/27/2020Morgan StanleyBoost TargetOverweight$82.00 ➝ $85.00
3/6/2020Deutsche Bank AktiengesellschaftLower TargetBuy$84.00 ➝ $82.00
2/18/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$68.00 ➝ $84.00
2/7/2020The Goldman Sachs GroupInitiated CoverageBuy$80.00
2/5/2020CitigroupBoost TargetBuy$65.00 ➝ $72.00
2/5/2020JPMorgan Chase & Co.Initiated CoverageNeutral ➝ Overweight$88.00
2/5/2020Credit Suisse GroupBoost TargetNeutral$65.00 ➝ $72.50
2/4/2020OppenheimerInitiated CoverageBuy$83.00
2/3/2020Evercore ISIInitiated CoverageOutperform$90.00
1/28/2020Sanford C. BernsteinBoost TargetTop Pick$84.00 ➝ $103.00
1/24/2020SunTrust BanksReiterated RatingBuy$77.00 ➝ $85.00
1/24/2020Wells Fargo & CompanyBoost TargetOverweight$72.00 ➝ $85.00
1/8/2020Credit Suisse GroupBoost TargetNeutral$57.00 ➝ $65.00
1/6/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$72.00
12/16/2019Piper Sandler CompaniesReiterated RatingBuy$80.00
12/16/2019BMO Capital MarketsBoost TargetPositive ➝ Outperform$65.00 ➝ $70.00
(Data available from 11/21/2019 forward)

News Sentiment Rating

0.71 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 21 very positive mentions
  • 30 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
4/25/2024
  • 35 very positive mentions
  • 35 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
5/25/2024
  • 32 very positive mentions
  • 15 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 21 very positive mentions
  • 17 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
7/24/2024
  • 31 very positive mentions
  • 42 positive mentions
  • 8 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 34 very positive mentions
  • 32 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 22 very positive mentions
  • 49 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
10/22/2024
  • 35 very positive mentions
  • 41 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
Mentions as of
11/21/2024

Current Sentiment

  • 35 very positive mentions
  • 41 positive mentions
  • 5 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Centene logo
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
Read More

Today's Range

Now: $59.10
Low: $58.00
High: $59.44

50 Day Range

MA: $67.27
Low: $57.45
High: $76.57

52 Week Range

Now: $59.10
Low: $57.20
High: $81.42

Volume

4,201,214 shs

Average Volume

4,024,332 shs

Market Capitalization

$29.84 billion

P/E Ratio

10.26

Dividend Yield

N/A

Beta

0.49

Frequently Asked Questions

What sell-side analysts currently cover shares of Centene?

The following equities research analysts have issued stock ratings on Centene in the last twelve months: Baird R W, Barclays PLC, Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., JPMorgan Chase & Co., Oppenheimer Holdings Inc., Robert W. Baird, Sanford C. Bernstein, Stephens, StockNews.com, TD Cowen, Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for CNC.

What is the current price target for Centene?

0 Wall Street analysts have set twelve-month price targets for Centene in the last year. Their average twelve-month price target is $83.92, suggesting a possible upside of 42.0%. Oppenheimer Holdings Inc. has the highest price target set, predicting CNC will reach $95.00 in the next twelve months. Robert W. Baird has the lowest price target set, forecasting a price of $66.00 for Centene in the next year.
View the latest price targets for CNC.

What is the current consensus analyst rating for Centene?

Centene currently has 7 hold ratings and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for CNC.

What other companies compete with Centene?

Other companies that are similar to Centene include Elevance Health, The Cigna Group, Humana, Molina Healthcare and UnitedHealth Group. Learn More about companies similar to Centene.

How do I contact Centene's investor relations team?

Centene's physical mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company's listed phone number is (314) 725-4477 and its investor relations email address is [email protected]. The official website for Centene is www.centene.com. Learn More about contacing Centene investor relations.